Testing effectiveness (Phase 2)UnknownNCT01830504What this trial is testingPhase II Pilot Open LabelWho this might be right forThyroid Cancers Hospices Civils de Lyon 47
Large-scale testing (Phase 3)Looking for participantsNCT06475989What this trial is testingStudy of Targeted Therapy vs. Chemotherapy in Patients With Thyroid CancerWho this might be right forRefractory Differentiated Thyroid Gland Carcinoma ECOG-ACRIN Cancer Research Group 264
Testing effectiveness (Phase 2)Study completedNCT02614495What this trial is testingStudy of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid CarcinomaWho this might be right forThyroid Carcinoma Hutchison Medipharma Limited 66
Large-scale testing (Phase 3)Active Not RecruitingNCT04940052What this trial is testingStudy of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid CancerWho this might be right forDifferentiated Thyroid Cancer (DTC) Novartis Pharmaceuticals 153
Testing effectiveness (Phase 2)Study completedNCT02702388What this trial is testingA Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety ProfileWho this might be right forThyroid Cancer Eisai Inc. 241
Not applicableApproved For MarketingNCT03533361What this trial is testingExpanded Access Program With Lenvatinib for the Treatment of Differentiated Thyroid Cancer in BrazilWho this might be right forThyroid Cancer Eisai Inc.
Early research (Phase 1)Active Not RecruitingNCT04514484What this trial is testingTesting the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVWho this might be right forAdvanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more National Cancer Institute (NCI) 8
Large-scale testing (Phase 3)Ended earlyNCT03602495What this trial is testingDonafenib in Patients With Radioiodine-refractory Differentiated Thyroid CancerWho this might be right forDifferentiated Thyroid Cancer Suzhou Zelgen Biopharmaceuticals Co.,Ltd 204
Not applicableUnknownNCT04858867What this trial is testingReinducing Radioiodine-sensitivity in Radioiodine-refractory DTC Using Lenvatinib (RESET)Who this might be right forDifferentiated Thyroid Cancer Leiden University Medical Center 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03914300What this trial is testingTesting the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid CancerWho this might be right forDifferentiated Thyroid Gland CarcinomaFollicular Variant Thyroid Gland Papillary CarcinomaPoorly Differentiated Thyroid Gland Carcinoma+6 more National Cancer Institute (NCI) 11
Not applicableUnknownNCT06062563What this trial is testingStudy of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid CancerWho this might be right forLocally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Peking Union Medical College Hospital 10
Testing effectiveness (Phase 2)Study completedNCT02973997What this trial is testingLenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)Who this might be right forColumnar Cell Variant Thyroid Gland Papillary CarcinomaFollicular Variant Thyroid Gland Papillary CarcinomaMetastatic Thyroid Gland Follicular Carcinoma+23 more Academic and Community Cancer Research United 57
Large-scale testing (Phase 3)Study completedNCT02966093What this trial is testingA Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in ChinaWho this might be right forDifferentiated Thyroid Cancer (DTC) Eisai Co., Ltd. 151
Early research (Phase 1)Study completedNCT01413113What this trial is testingIodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By SurgeryWho this might be right forRecurrent Thyroid CancerStage IVA Follicular Thyroid CancerStage IVA Papillary Thyroid Cancer+4 more University of Washington 6
Testing effectiveness (Phase 2)UnknownNCT03167385What this trial is testingPhase 2 Trial of Apatinib Mesylate in Locally Advanced/Metastatic Differentiated Thyroid CarcinomaWho this might be right forDifferentiated Thyroid Carcinoma Tianjin Medical University Cancer Institute and Hospital 20
Testing effectiveness (Phase 2)Study completedNCT01811212What this trial is testingCabozantinib-S-Malate in Treating Patients With Refractory Thyroid CancerWho this might be right forPoorly Differentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland CarcinomaStage I Thyroid Gland Follicular Carcinoma+13 more National Cancer Institute (NCI) 25
Large-scale testing (Phase 3)UnknownNCT02586337What this trial is testingStudy of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032)Who this might be right forDifferentiated Thyroid Cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 113
Large-scale testing (Phase 3)Active Not RecruitingNCT03690388What this trial is testingCabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted TherapyWho this might be right forDifferentiated Thyroid Cancer Exelixis 187
Early research (Phase 1)Active Not RecruitingNCT04420754What this trial is testingStudy of AIC100 CAR T Cells in Relapsed/Refractory Thyroid CancerWho this might be right forAnaplastic Thyroid CancerRelapsed/Refractory Poorly Differentiated Thyroid Cancer AffyImmune Therapeutics, Inc. 70
Early research (Phase 1)Study completedNCT04462471What this trial is testingVemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid CancersWho this might be right forThyroid CarcinomaThyroid CancerThyroid Cancer, Follicular+3 more Memorial Sloan Kettering Cancer Center 8